Varian Medical Systems Adds High Dose Delivery and Prone Breast Treatment Capabilities to Clinac and Trilogy Cancer

Symbols: VAR
Posted in: News, FDA
Share

Clinac and Trilogy medical linear accelerators from Varian Medical Systems (NYSE: VAR), machines that are used to treat cancer with targeted radiotherapy, have been updated to deliver higher doses up to two times faster than was previously possible.  They can now also better facilitate treating breast cancer patients on their stomachs rather than their backs—an approach that can reduce the volume of lung and heart tissue exposed to radiation during treatment.


 
 
< Previous
Linktone Purchases Additional $5 Million of Global Mediacom Tbk Shares; Increasing from 2.2% to 2.5% of Shares Outstanding
Next >
Landauer Reports Q4 EPS $0.54 vs. $0.55; Revenues $30.5M vs $30.95M Est
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust